• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS, INC VENACURE NEVERTOUCH FIBER; VENACURE ENDOVENOUS LASER TREATMENT FIBER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS, INC VENACURE NEVERTOUCH FIBER; VENACURE ENDOVENOUS LASER TREATMENT FIBER Back to Search Results
Catalog Number NOT REPORTED
Device Problem Unsealed Device Packaging (1444)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/05/2019
Event Type  malfunction  
Manufacturer Narrative
It was reported that the disposable device was discarded by the user and is not available to be returned to the manufacturer for evaluation.The results of the device evaluation will be sent via a follow up medwatch.Reference complaint # (b)(4).
 
Event Description
As reported : the account reported they had received three nevertouch 65cm convenience kit packages that were opened.Therefore the product was no longer sterile.The opened packages were noticed while prepping for an evlt procedure in a sterile setting.One of the packages appeared to be sealed, but was not.The other two were opened about 2 inches or smaller.There was no air in the package.Also, no photos can be provided.This was noticed during the procedure.They first opened the microaccess kit, waited for access, then saw that fiber package was not sealed properly.All three pouches were not noticed at the same time.It was only noticed right before the fiber was needed for the procedure.They currently hang the pouches.It was reported the packages are not available for return to the manufacturer for a an evaluation as it was disposed of by the user.
 
Manufacturer Narrative
As the reported defective device was not returned, angiodynamics is unable to perform a device evaluation.The customer's reported complaint of "packaging was not sealed" was not confirmed; no product was returned and photo's weren't provided.Without receiving product for evaluation we cannot determine the root cause for the sterility breach.A lot history records search, obtained via ship history, revealed no quality related issues or manufacturing deficiencies at the time of manufacture.A potential root cause is handling damage after leaving the angiodynamics facility.A review of the angiodynamics' device history records was performed for the reported packaging and component lots for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly, and performance specifications.A review of the angiodynamics complaint system noted no trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Reference complaint (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENACURE NEVERTOUCH FIBER
Type of Device
VENACURE ENDOVENOUS LASER TREATMENT FIBER
Manufacturer (Section D)
ANGIODYNAMICS, INC
603 queensbury avenue
queensbury, ny NY 12804
MDR Report Key9535479
MDR Text Key175931844
Report Number1319211-2019-00123
Device Sequence Number1
Product Code GEX
Combination Product (y/n)N
PMA/PMN Number
K171921
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 02/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/31/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberNOT REPORTED
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received12/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-